Daniela Santos Masson-Meyers

Daniela Santos Masson-Meyers

Auto-generated profile, based on publicly available information

Daniela Santos Masson-Meyers

College of Health and Human Services, San Diego State University, 5500 Campanile Dr, San Diego, CA 92182, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in International Journal of Experimental Pathology
Verified
Journal Article
Open access
PDF file
DMDaniela S. Masson‐Meyers
Daniela S. Masson‐Meyers
TAThiago Andrade
Thiago Andrade
GCGuilherme Caetano
Guilherme Caetano
FGFrancielle R. Guimaraes
Francielle R. Guimaraes
MLMarcel Nani Leite
Marcel Nani Leite
MFMaria Lucia Frade
Maria Lucia Frade
Summary: Wound healing studies are intricate, mainly because of the multifaceted nature of the wound environment and the complexity of the healing process, which integrates a variety of cells and repair phases, including inflammation, proliferation, reepithelialization and remodelling. There are a variety of possible preclinical models, such as in mice, rabbits and pigs, which can be used to mimic acute or impaired for example, diabetic and nutrition‐related wounds. These can be induced by many different techniques, with excision or incision being the most common. After determining a suitable model for a study, investigators need to select appropriate and reproducible methods that will allow the monitoring of the wound progression over time. The assessment can be performed by non‐invasive protocols such as wound tracing, photographic documentation (including image analysis), biophysical techniques and/or by invasive protocols that will require wound biopsies. In this article, we provide an overview of some of the most often needed and used: (a) preclinical/animal models including incisional, excisional, burn and impaired wounds; (b) methods to evaluate the healing progression such as wound healing rate, wound analysis by image, biophysical assessment, histopathological, immunological and biochemical assays. The aim is to help researchers during the design and execution of their wound healing studies.

31 May 2021 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
DMDaniela Santos Masson‐Meyers
Daniela Santos Masson‐Meyers
LTLobat Tayebi
Lobat Tayebi

1 May 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
GBGabriel Biener
Gabriel Biener
DMDaniela S. Masson-Meyers
Daniela S. Masson-Meyers
VBViolet V. Bumah
Violet V. Bumah
GHGrant Hussey
Grant Hussey
MSMichael R. Stoneman
Michael R. Stoneman
VRValerica Raicu
Valerica Raicu

1 September 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TAThiago Andrade
Thiago Andrade
DMDaniela Santos Masson-Meyers
Daniela Santos Masson-Meyers
GCGuilherme Ferreira Caetano
Guilherme Ferreira Caetano
VTVânia Aparecida Terra
Vânia Aparecida Terra
POPaula Payão Ovidio
Paula Payão Ovidio
MFMaria Lucia Frade
Maria Lucia Frade

1 June 2020 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Open access
Chukuka EnwemekaChukuka Enwemeka
Chukuka Enwemeka
VBViolet Bumah
Violet Bumah
DMDaniela Santos Masson-Meyers
Daniela Santos Masson-Meyers
The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy—one of the most effective treatments used to reduce the impact of the 1918 “Spanish influenza” pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400–470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.

1 July 2016 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
DMDaniela Santos Masson-Meyers
Daniela Santos Masson-Meyers
VBViolet Vakunseh Bumah
Violet Vakunseh Bumah
Chukuka EnwemekaChukuka Enwemeka
Chukuka Enwemeka